Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

331 ARTÍCULOS , VIENDO DEL 151 AL 165

The impact of supplemental macular carotenoids in Alzheimer's disease: a randomized clinical trial

Nolan JM, Loskutova E, Howard A, Mulcahy R, Moran R, Stack J, Bolger M, Coen RF, Dennison J, Akuffo KO, Owens N, Power R, Thurnham D, Beatty S.

J Alzheimers Dis. 2015;44(4):1157-69. doi: 10.3233/JAD-142265.

Evaluating high-dose rivastigmine patch in severe Alzheimer's disease: analyses with concomitant memantine usage as a factor

Grossberg GT, Farlow MR, Meng X, Velting DM.

Curr Alzheimer Res. 2015;12(1):53-60. doi: 10.2174/1567205011666141218122835.

New horizons in the management of Alzheimer disease

Morley JE.

J Am Med Dir Assoc. 2015 Jan;16(1):1-5. doi: 10.1016/j.jamda.2014.10.022.

Cognitive-motor intervention in Alzheimer's disease: long-term results from the Maria Wolff trial

Muñiz R, Serra CM, Reisberg B, Rojo JM, Del Ser T, Peña Casanova J, Olazarán J.

J Alzheimers Dis. 2015;45(1):295-304. doi: 10.3233/JAD-142364.

Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer's disease

Wischik CM, Staff RT, Wischik DJ, Bentham P, Murray AD, Storey JM, Kook KA, Harrington CR.

J Alzheimers Dis. 2015;44(2):705-20. doi: 10.3233/JAD-142874.

A disease that strikes close to home

Hickner J.

J Fam Pract. 2015 Jan;64(1):8.

The effectiveness of reality orientation in the treatment of Alzheimer's disease

Camargo CH, Justus FF, Retzlaff G.

Am J Alzheimers Dis Other Demen. 2015 Aug;30(5):527-32. doi: 10.1177/1533317514568004. Epub 2015 Jan 14.

Melatonin for sleep disorders and cognition in dementia: a meta-analysis of randomized controlled trials

Xu J, Wang LL, Dammer EB, Li CB, Xu G, Chen SD, Wang G.

Am J Alzheimers Dis Other Demen. 2015 Aug;30(5):439-47. doi: 10.1177/1533317514568005.

Intervention of multi-modal activities for older adults with dementia translation to rural communities

La Rue A, Felten K, Turkstra L.

Am J Alzheimers Dis Other Demen. 2015 Aug;30(5):468-77. doi: 10.1177/1533317514568888. Epub 2015 Feb 4.

Evaluating Response to High-Dose 13.3 mg/24 h Rivastigmine Patch in Patients with Severe Alzheimer's Disease

Farlow MR, Sadowsky CH, Velting DM, Meng X, Islam MZ.

CNS Neurosci Ther. 2015 Jun;21(6):513-9. doi: 10.1111/cns.12385. Epub 2015 Feb 10.

Differences in Alzheimer disease clinical trial outcomes based on age of the participants

Schneider LS, Kennedy RE, Wang G, Cutter GR.

Neurology. 2015 Mar 17;84(11):1121-7. doi: 10.1212/WNL.0000000000001376. Epub 2015 Feb 13.

A Pilot Evaluation of Psychosocial Support for Family Caregivers of Relatives with Dementia in Long-Term Care: The Residential Care Transition Module

Gaugler JE, Reese M, Sauld J.

Res Gerontol Nurs. 2015 Jul-Aug;8(4):161-72. doi: 10.3928/19404921-20150304-01. Epub 2015 Mar 10.

Memantine overdose in a non-demented older adult

Safer U, Doruk H, Tasci I.

Geriatr Gerontol Int. 2015 Mar;15(3):383. doi: 10.1111/ggi.12375.

Cannabinoids in late-onset Alzheimer's disease

Ahmed A, van der Marck MA, van den Elsen G, Olde Rikkert M.

Clin Pharmacol Ther. 2015 Jun;97(6):597-606. doi: 10.1002/cpt.117. Epub 2015 Apr 17.

[Dementia: an interdisciplinary challenge!]

Kressig RW.

Ther Umsch. 2015 Apr;72(4):211. doi: 10.1024/0040-5930/a000666.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias